Abstract
The novel SST3 agonist ITF2984 exerts antimitotic and proapoptotic effects in human non-functioning pituitary neuroendocrine tumor (NF-PitNET) cells
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have